Suppr超能文献

西班牙的血浆置换管理

Management of plasmapheresis in Spain.

作者信息

Ordinas A

机构信息

Hematology Department, Servicio Hemoterapia y Hemostasia, Hospital Clinic i Provincial de Barcelona, Spain.

出版信息

Hematol Cell Ther. 1996 May;38 Suppl 1:S3-7.

PMID:8933141
Abstract

In Spain, there is no specific regulation for plasmapheresis. At the present time, there are two decrees issued by the central government that regulate blood donation and blood banks operation. The seventeen autonomous regions have independent powers including health care. Regulation at this level is possible, but not currently in place. In 1993, 1,266,704 units of whole blood were collected in Spain. This whole blood donation was enough to cover the need for red blood cells, but not to cover the needs of plasma derivatives. It has been calculated that in order to fulfil the requirements of factor and albumin about 400,0001 of plasma are needed. In 1994, there were over 10 centres in Spain where there were ongoing plasmapheresis programmes. Other centres are preparing plasmapheresis programmes scheduled to start in 1995. Spain needs an extra amount of plasma in between 250,000 and 300,0001 to cover the needs of plasma derivatives. It is concluded that it is probably best to meet plasma derivatives requirements with plasma obtained from a plasmapheresis programme. This approach has mainly two advantages: -the plasma generated is of the best quality available in order to produce coagulation factor concentrates; -it does not produce a "by-product" that in principle is not needed and would be unethical to throw away. We believe that to achieve self-sufficiency in plasma donation throughout a plasmapheresis programme requires flexibility in the current law and a substantial investment in promotion programmes.

摘要

在西班牙,对于血浆置换没有具体的规定。目前,中央政府发布了两项法令来规范献血和血库运营。17个自治区拥有包括医疗保健在内的独立权力。在这一层面进行规范是可行的,但目前尚未实施。1993年,西班牙采集了1,266,704单位的全血。这些全血捐献足以满足红细胞的需求,但无法满足血浆衍生物的需求。据计算,为了满足凝血因子和白蛋白的需求,大约需要400,000升血浆。1994年,西班牙有超过10个中心正在开展血浆置换项目。其他中心正在筹备计划于1995年启动的血浆置换项目。西班牙需要额外250,000至300,000升血浆来满足血浆衍生物的需求。结论是,用从血浆置换项目中获得的血浆来满足血浆衍生物的需求可能是最好的办法。这种方法主要有两个优点:一是产生的血浆质量上乘,可用于生产凝血因子浓缩物;二是不会产生原则上不需要且丢弃不道德的“副产品”。我们认为,要通过血浆置换项目实现血浆捐献的自给自足,需要现行法律具备灵活性,并在推广项目上进行大量投资。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验